Biotech Still Leading

02/10/2009 9:43 am EST


Thomas Aspray

, Professional Trader & Analyst


The S&P biotech sector has had positive relative performance since last summer, and last week, it broke a short-term downtrend. Since the end of 2007, the biotech sector is up 6.6%, while the S&P 500 is down 39.2%. As noted before, the breakout above five-and-a-half year resistance does appear to be significant.

  By clicking submit, you agree to our privacy policy & terms of service.

Related Articles on STOCKS